{"id":28069,"date":"2018-11-06T00:00:00","date_gmt":"2018-11-06T05:00:00","guid":{"rendered":"http:\/\/ashleydev.com\/2018\/11\/06\/leukemia-patients-turn-to-nuclear-3\/"},"modified":"2020-08-27T11:26:45","modified_gmt":"2020-08-27T15:26:45","slug":"leukemia-patients-turn-to-nuclear-3","status":"publish","type":"post","link":"https:\/\/cna.ca\/fr\/2018\/11\/06\/leukemia-patients-turn-to-nuclear-3\/","title":{"rendered":"Leukemia patients turn to nuclear"},"content":{"rendered":"

\"\"<\/p>\n

German researchers say targeted alpha therapy can provide hope for men with prostate cancer by using a nuclear isotope.<\/p>\n

Their findings were published in the October issue of The Journal of Nuclear Medicine<\/a>, in an article that concluded that using the isotope actinium-225 \u201cis tolerable and presents promising antitumor activity\u201d and that repeated treatments \u201cmay lead to continuing tumor control.\u201d<\/p>\n

Actinium-225 is also being used with great success<\/a> in helping patients newly diagnosed with Acute Myeloid Leukemia.<\/p>\n

\u201cActinium-225, an isotope of the element actinium, which is usually found in uranium ores, is proving effective in curing – not just treating – myeloid leukemia,\u201d USA Today reported in May.<\/p>\n

Oak Ridge National Labs (ORNL) is the only source for Actinium-225, which has been found to save lives in clinical trials.<\/p>\n

Actinium is a byproduct of Uranium-233, which the United States produced for ORNL’s Molten Salt Reactor Experiment in the 1960s. Researchers at Oak Ridge are using waste that has sat in steel barrels for decades to obtain the isotope.<\/p>\n

The cancer was previously treatable in young patients only. That is a problem since the average age diagnosis is 67 years old. The new therapy using Actinium-225, has successfully treated elderly patients, according to Oak Ridge nuclear medical scientist Saed Mirzadeh, who added that some patients went into remission after only one treatment.<\/p>\n

Oak Ridge researchers also say that the isotope could be used to treat prostate cancer and brain tumors. Multiple clinical trials are taking place in Europe for those cancers, but there are currently no such trials in North America.<\/p>\n","protected":false},"excerpt":{"rendered":"

German researchers say targeted alpha therapy can provide hope for men with prostate cancer by using a nuclear isotope. Their findings were published in the October issue of The Journal of Nuclear Medicine, in an article that concluded that using the isotope actinium-225 \u201cis tolerable and presents promising antitumor activity\u201d and that repeated treatments \u201cmay […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[537],"tags":[],"topic":[],"class_list":["post-28069","post","type-post","status-publish","format-standard","hentry","category-talknuclear"],"acf":[],"yoast_head":"\nLeukemia patients turn to nuclear - Association nucl\u00e9aire canadienne<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cna.ca\/fr\/2018\/11\/06\/leukemia-patients-turn-to-nuclear-3\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Leukemia patients turn to nuclear - Association nucl\u00e9aire canadienne\" \/>\n<meta property=\"og:description\" content=\"German researchers say targeted alpha therapy can provide hope for men with prostate cancer by using a nuclear isotope. Their findings were published in the October issue of The Journal of Nuclear Medicine, in an article that concluded that using the isotope actinium-225 \u201cis tolerable and presents promising antitumor activity\u201d and that repeated treatments \u201cmay […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cna.ca\/fr\/2018\/11\/06\/leukemia-patients-turn-to-nuclear-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Association nucl\u00e9aire canadienne\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/canadanuclear\" \/>\n<meta property=\"article:published_time\" content=\"2018-11-06T05:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-08-27T15:26:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cna.ca\/wp-content\/uploads\/2018\/06\/cancer-editorial.jpg\" \/>\n<meta name=\"author\" content=\"cna_admin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"cna_admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/2018\\\/11\\\/06\\\/leukemia-patients-turn-to-nuclear-3\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/2018\\\/11\\\/06\\\/leukemia-patients-turn-to-nuclear-3\\\/\"},\"author\":{\"name\":\"cna_admin\",\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/#\\\/schema\\\/person\\\/b0c8179b9b04ade90057bc7a30b2fbd2\"},\"headline\":\"Leukemia patients turn to nuclear\",\"datePublished\":\"2018-11-06T05:00:00+00:00\",\"dateModified\":\"2020-08-27T15:26:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/2018\\\/11\\\/06\\\/leukemia-patients-turn-to-nuclear-3\\\/\"},\"wordCount\":265,\"publisher\":{\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/2018\\\/11\\\/06\\\/leukemia-patients-turn-to-nuclear-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cna.ca\\\/wp-content\\\/uploads\\\/2018\\\/06\\\/cancer-editorial.jpg\",\"articleSection\":[\"Talk Nuclear\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/2018\\\/11\\\/06\\\/leukemia-patients-turn-to-nuclear-3\\\/\",\"url\":\"https:\\\/\\\/cna.ca\\\/fr\\\/2018\\\/11\\\/06\\\/leukemia-patients-turn-to-nuclear-3\\\/\",\"name\":\"Leukemia patients turn to nuclear - Association nucl\u00e9aire canadienne\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/2018\\\/11\\\/06\\\/leukemia-patients-turn-to-nuclear-3\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/2018\\\/11\\\/06\\\/leukemia-patients-turn-to-nuclear-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cna.ca\\\/wp-content\\\/uploads\\\/2018\\\/06\\\/cancer-editorial.jpg\",\"datePublished\":\"2018-11-06T05:00:00+00:00\",\"dateModified\":\"2020-08-27T15:26:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/2018\\\/11\\\/06\\\/leukemia-patients-turn-to-nuclear-3\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cna.ca\\\/fr\\\/2018\\\/11\\\/06\\\/leukemia-patients-turn-to-nuclear-3\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/2018\\\/11\\\/06\\\/leukemia-patients-turn-to-nuclear-3\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cna.ca\\\/wp-content\\\/uploads\\\/2018\\\/06\\\/cancer-editorial.jpg\",\"contentUrl\":\"https:\\\/\\\/cna.ca\\\/wp-content\\\/uploads\\\/2018\\\/06\\\/cancer-editorial.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/2018\\\/11\\\/06\\\/leukemia-patients-turn-to-nuclear-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/cna.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Leukemia patients turn to nuclear\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/cna.ca\\\/fr\\\/\",\"name\":\"Canadian Nuclear Association\",\"description\":\"The national voice of the Canadian nuclear industry since 1960\",\"publisher\":{\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cna.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/#organization\",\"name\":\"Canadian Nuclear Association\",\"url\":\"https:\\\/\\\/cna.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/cna.ca\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/cropped-cna-logo-only.png\",\"contentUrl\":\"https:\\\/\\\/cna.ca\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/cropped-cna-logo-only.png\",\"width\":512,\"height\":512,\"caption\":\"Canadian Nuclear Association\"},\"image\":{\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"http:\\\/\\\/www.facebook.com\\\/canadanuclear\",\"https:\\\/\\\/x.com\\\/canadanuclear\",\"https:\\\/\\\/www.instagram.com\\\/canadanuclear\",\"https:\\\/\\\/www.youtube.com\\\/CanadaNuclear\",\"http:\\\/\\\/www.linkedin.com\\\/company\\\/canadian-nuclear-association\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/#\\\/schema\\\/person\\\/b0c8179b9b04ade90057bc7a30b2fbd2\",\"name\":\"cna_admin\",\"url\":\"https:\\\/\\\/cna.ca\\\/fr\\\/author\\\/cna_admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Leukemia patients turn to nuclear - Association nucl\u00e9aire canadienne","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cna.ca\/fr\/2018\/11\/06\/leukemia-patients-turn-to-nuclear-3\/","og_locale":"fr_FR","og_type":"article","og_title":"Leukemia patients turn to nuclear - Association nucl\u00e9aire canadienne","og_description":"German researchers say targeted alpha therapy can provide hope for men with prostate cancer by using a nuclear isotope. Their findings were published in the October issue of The Journal of Nuclear Medicine, in an article that concluded that using the isotope actinium-225 \u201cis tolerable and presents promising antitumor activity\u201d and that repeated treatments \u201cmay […]","og_url":"https:\/\/cna.ca\/fr\/2018\/11\/06\/leukemia-patients-turn-to-nuclear-3\/","og_site_name":"Association nucl\u00e9aire canadienne","article_publisher":"http:\/\/www.facebook.com\/canadanuclear","article_published_time":"2018-11-06T05:00:00+00:00","article_modified_time":"2020-08-27T15:26:45+00:00","og_image":[{"url":"https:\/\/cna.ca\/wp-content\/uploads\/2018\/06\/cancer-editorial.jpg","type":"","width":"","height":""}],"author":"cna_admin","twitter_misc":{"Written by":"cna_admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cna.ca\/fr\/2018\/11\/06\/leukemia-patients-turn-to-nuclear-3\/#article","isPartOf":{"@id":"https:\/\/cna.ca\/fr\/2018\/11\/06\/leukemia-patients-turn-to-nuclear-3\/"},"author":{"name":"cna_admin","@id":"https:\/\/cna.ca\/fr\/#\/schema\/person\/b0c8179b9b04ade90057bc7a30b2fbd2"},"headline":"Leukemia patients turn to nuclear","datePublished":"2018-11-06T05:00:00+00:00","dateModified":"2020-08-27T15:26:45+00:00","mainEntityOfPage":{"@id":"https:\/\/cna.ca\/fr\/2018\/11\/06\/leukemia-patients-turn-to-nuclear-3\/"},"wordCount":265,"publisher":{"@id":"https:\/\/cna.ca\/fr\/#organization"},"image":{"@id":"https:\/\/cna.ca\/fr\/2018\/11\/06\/leukemia-patients-turn-to-nuclear-3\/#primaryimage"},"thumbnailUrl":"https:\/\/cna.ca\/wp-content\/uploads\/2018\/06\/cancer-editorial.jpg","articleSection":["Talk Nuclear"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/cna.ca\/fr\/2018\/11\/06\/leukemia-patients-turn-to-nuclear-3\/","url":"https:\/\/cna.ca\/fr\/2018\/11\/06\/leukemia-patients-turn-to-nuclear-3\/","name":"Leukemia patients turn to nuclear - Association nucl\u00e9aire canadienne","isPartOf":{"@id":"https:\/\/cna.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cna.ca\/fr\/2018\/11\/06\/leukemia-patients-turn-to-nuclear-3\/#primaryimage"},"image":{"@id":"https:\/\/cna.ca\/fr\/2018\/11\/06\/leukemia-patients-turn-to-nuclear-3\/#primaryimage"},"thumbnailUrl":"https:\/\/cna.ca\/wp-content\/uploads\/2018\/06\/cancer-editorial.jpg","datePublished":"2018-11-06T05:00:00+00:00","dateModified":"2020-08-27T15:26:45+00:00","breadcrumb":{"@id":"https:\/\/cna.ca\/fr\/2018\/11\/06\/leukemia-patients-turn-to-nuclear-3\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cna.ca\/fr\/2018\/11\/06\/leukemia-patients-turn-to-nuclear-3\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/cna.ca\/fr\/2018\/11\/06\/leukemia-patients-turn-to-nuclear-3\/#primaryimage","url":"https:\/\/cna.ca\/wp-content\/uploads\/2018\/06\/cancer-editorial.jpg","contentUrl":"https:\/\/cna.ca\/wp-content\/uploads\/2018\/06\/cancer-editorial.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/cna.ca\/fr\/2018\/11\/06\/leukemia-patients-turn-to-nuclear-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cna.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Leukemia patients turn to nuclear"}]},{"@type":"WebSite","@id":"https:\/\/cna.ca\/fr\/#website","url":"https:\/\/cna.ca\/fr\/","name":"Canadian Nuclear Association","description":"The national voice of the Canadian nuclear industry since 1960","publisher":{"@id":"https:\/\/cna.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cna.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/cna.ca\/fr\/#organization","name":"Canadian Nuclear Association","url":"https:\/\/cna.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/cna.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/cna.ca\/wp-content\/uploads\/2023\/12\/cropped-cna-logo-only.png","contentUrl":"https:\/\/cna.ca\/wp-content\/uploads\/2023\/12\/cropped-cna-logo-only.png","width":512,"height":512,"caption":"Canadian Nuclear Association"},"image":{"@id":"https:\/\/cna.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["http:\/\/www.facebook.com\/canadanuclear","https:\/\/x.com\/canadanuclear","https:\/\/www.instagram.com\/canadanuclear","https:\/\/www.youtube.com\/CanadaNuclear","http:\/\/www.linkedin.com\/company\/canadian-nuclear-association"]},{"@type":"Person","@id":"https:\/\/cna.ca\/fr\/#\/schema\/person\/b0c8179b9b04ade90057bc7a30b2fbd2","name":"cna_admin","url":"https:\/\/cna.ca\/fr\/author\/cna_admin\/"}]}},"_links":{"self":[{"href":"https:\/\/cna.ca\/fr\/wp-json\/wp\/v2\/posts\/28069","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cna.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cna.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cna.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cna.ca\/fr\/wp-json\/wp\/v2\/comments?post=28069"}],"version-history":[{"count":1,"href":"https:\/\/cna.ca\/fr\/wp-json\/wp\/v2\/posts\/28069\/revisions"}],"predecessor-version":[{"id":28490,"href":"https:\/\/cna.ca\/fr\/wp-json\/wp\/v2\/posts\/28069\/revisions\/28490"}],"wp:attachment":[{"href":"https:\/\/cna.ca\/fr\/wp-json\/wp\/v2\/media?parent=28069"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cna.ca\/fr\/wp-json\/wp\/v2\/categories?post=28069"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cna.ca\/fr\/wp-json\/wp\/v2\/tags?post=28069"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/cna.ca\/fr\/wp-json\/wp\/v2\/topic?post=28069"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}